| Gold drugs: mechanism of action and toxicity SL Best, PJ Sadler Gold bulletin 29, 87-93, 1996 | 183 | 1996 |
| Dual effect of ATP in the activation mechanism of brain Ca2+/calmodulin-dependent protein kinase II by Ca2+/calmodulin K Török, A Tzortzopoulos, Z Grabarek, SL Best, R Thorogate Biochemistry 40 (49), 14878-14890, 2001 | 70 | 2001 |
| Gold (III) and Palladium (II) Complexes of Glycylglycyl-L-Histidine: Crystal Structures of [Au III (Gly-Gly-L-His-H-2)] Cl· H 2 O and [Pd II (Gly-Gly-L-His-H-2)]· 1.5 H 2 O and … SL Best, TK Chattopadhyay, MI Djuran, RA Palmer, PJ Sadler, I Sóvágó, ... Journal of the Chemical Society, Dalton Transactions, 2587-2596, 1997 | 70 | 1997 |
| T cell cross‐reactivity to heavy metals: identical cryptic peptides may be presented from protein exposed to different metals P Griem, C von Vultée, K Panthel, SL Best, PJ Sadler, CF Shaw III European journal of immunology 28 (6), 1941-1947, 1998 | 61 | 1998 |
| Impact of informational and relational continuity for people with palliative care needs: a mixed methods rapid review BN BF Hudson, S Best, P Stone BMJ Open 9 (5), 1-14, 2019 | 28* | 2019 |
| Ca2+/calmodulin-dependent activation and inactivation mechanisms of αCaMKII and phospho-Thr286-αCaMKII A Tzortzopoulos, SL Best, D Kalamida, K Török Biochemistry 43 (20), 6270-6280, 2004 | 21 | 2004 |
| Research priority setting in palliative and end of life care: the James Lind Alliance approach consulting patients, carers and clinicians S Best, T Tate, B Noble, R Smith, J Tuft, N Tracey, A McCullugh, J Eley, ... BMJ supportive & palliative care 5 (1), 102-102, 2015 | 19 | 2015 |
| [AU (DIEN) Cl] Cl2: Exchange Phenomena Observed by 1H and 13C NMR Spectroscopy SL Best, Z Guo, MI Djuran, PJ Sadler Metal-based drugs 6 (4-5), 261, 1999 | 14 | 1999 |
| A two-state model for Ca2+/CaM-dependent protein kinase II (αCaMKII) in response to persistent Ca2+ stimulation in hippocampal neurons PAA Grant, SL Best, N Sanmugalingam, R Alessio, AM Jama, K Török Cell calcium 44 (5), 465-478, 2008 | 12 | 2008 |
| The palliative and end of life care priority setting partnership (PEOLCPSP): Determining evidence uncertainties from the perspective of the end user of research S Best, T Tate, B Noble, J Eley, J Black, M Stockton, A Cheesley, L Berry, ... BMJ Supportive & Palliative Care 4 (Suppl 1), A42-A42, 2014 | 9 | 2014 |
| Nickel contamination of gold salts: link with gold-induced skin rash. EH Choy, L Gambling, SL Best, RE Jenkins, E Kondeatis, R Vaughan, ... British journal of rheumatology 36 (10), 1054-1058, 1997 | 9 | 1997 |
| How current UK research addresses out of hours palliative care FT Fordham, S McMillan, S Best, B Candy, S Thakrar, B Noble BMJ Supportive & Palliative Care 6 (3), 384-384, 2016 | 6 | 2016 |
| Identifying palliative and end-of-life care research priorities: a UK approach to consult end users IM AG, E SO European Journal of Palliative Care 22 (3), 2015 | 6 | 2015 |
| 1., Palmer RA, Sadler PJ, Sóvàgó I., Varnagy KJ Chem. Soc SL Best, TK Chattopadhyay, M Djuran Dalton. Trans 2587, 1997 | 5 | 1997 |
| Does current UK research address priorities in palliative and end-of-life care? F Todd-Fordham, B Candy, S McMillan, S Best European Journal of Palliative Care 23 (6), 290-293, 2016 | 4 | 2016 |
| Hypervelocity impact facility for simulating materials exposure to impact by space debris MF Rose, S Best, T Chaloupka, B Stephens, G Crawford NASA. Langley Research Center, LDEF: 69 Months in Space. Second Post …, 1993 | 4 | 1993 |
| Top 10 living with and beyond cancer research priorities F Li, A Morgan, A McCullagh, A Johnson, C Giles, D Greenfield, ... Cancer Research 79 (13_Supplement), 3348-3348, 2019 | 3 | 2019 |
| Binding of [Au (dien) Cl] Cl2 to Tripeptides SL Best, MI Djuran, P Sadler Metal-Based Drugs 1 (5-6), 509, 1994 | 3 | 1994 |
| Development of a fluorescent glutamate-binding protein SL Best, K Torok Biophysical Journal 88 (1), 46A-47A, 2005 | 2 | 2005 |
| X-Ray Crystal Structure and Solution Properties of [Au (III)(H-2-Gly-Gly-L-His)] Cl. H2O SL Best, TK Chattopadhyay, MI Djuran, MA Mazid, RA Palmer, P Sadler Metal-Based Drugs 1 (5-6), 510, 1994 | 2 | 1994 |
